Preclinical study explores how a psychedelic drug repairs synaptic function in a mouse model of prenatal alcohol exposure, suggesting new therapeutic possibilities.
Psychedelic neuroplastogens may show promise as potential therapeutics for synaptic deficits associated with PAE and should be further explored in preclinical models.
No takes yet. Share an insight, caveat, or question.
Ekins et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: